Source MS Trust: Couples and families develop their own unique ways of dealing with an MS diagnosis. A recent UK study looked at how different family units affected by MS, cope with receiving MS health information. In this study, UK researchers wanted to understand how couples and families affected by MS cope with health information. The […]
How do families affected by MS manage health information Read More »
Source MS Society: We know around 90% of people with MS experience fatigue, which can severely impact their quality of life.
Research shows hot chocolate could help reduce fatigue Read More »
A ground-breaking clinical research trial is inviting people living with Multiple Sclerosis (MS) to take part in the evaluation of a balance exercise program using a robotic walking device.
Source Multiple Sclerosis News Today: Multiple sclerosis (MS) patients who began treatment with Gilenya (fingolimod) and stayed with it continuously showed a more than 50 percent reduction in annual relapse rates, a real-world study following these people for up to three years found.
Source Science Daily: Scientists have discovered a critical part of the body’s immune system with potentially major implications for the treatment of some of the most devastating diseases affecting humans.
Masterswitch discovered in body’s immune system Read More »
An invitation from the iStep-MS Trial Research Team: We would like to invite you to a free seminar at Brunel University London on Saturday 23rd February where we will share findings from the iStep-MS trial.
Source Multiple Sclerosis News Today: Stem cells tweaked in the laboratory have allowed researchers, reportedly for a first time, to generate and maintain ball-shaped cultures — called spheroids — of human brain cells in 3D that contain oligodendrocytes, the cells that produce myelin, along with neurons and the astrocytes that are essential to nerve cell health. These long-surviving
Source MS Trust: A letter signed by the MS Society, MS Trust, Shift MS and leading neurologists calls on NICE, NHS England and drug manufacturer Roche to make ocrelizumab available for people with primary progressive MS. Back in September, NICE announced that it would not be recommending ocrelizumab as an NHS treatment for early primary progressive MS.
Letter calls for ocrelizumab to be made available for people with PPMS Read More »
Source Independent Living: Exercise is frequently cited as a good way of helping to prevent falls, and now we have strong evidence that a programme of exercise can indeed prevent falls amongst older people living in the community.
Cochrane Review of effectiveness of exercise to prevent falls Read More »
Source MS Trust: People with relapsing remitting MS starting early treatment with a disease modifying drug have a lower risk of developing secondary progressive MS, according to a study of medical records.
Disease modifying drugs may reduce risk of secondary progressive MS Read More »
